These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 22543039)

  • 1. Plasmodium subtilisin-like protease 1 (SUB1): insights into the active-site structure, specificity and function of a pan-malaria drug target.
    Withers-Martinez C; Suarez C; Fulle S; Kher S; Penzo M; Ebejer JP; Koussis K; Hackett F; Jirgensons A; Finn P; Blackman MJ
    Int J Parasitol; 2012 May; 42(6):597-612. PubMed ID: 22543039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compound.
    Bouillon A; Giganti D; Benedet C; Gorgette O; Pêtres S; Crublet E; Girard-Blanc C; Witkowski B; Ménard D; Nilges M; Mercereau-Puijalon O; Stoven V; Barale JC
    J Biol Chem; 2013 Jun; 288(25):18561-73. PubMed ID: 23653352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico study of subtilisin-like protease 1 (SUB1) from different Plasmodium species in complex with peptidyl-difluorostatones and characterization of potent pan-SUB1 inhibitors.
    Brogi S; Giovani S; Brindisi M; Gemma S; Novellino E; Campiani G; Blackman MJ; Butini S
    J Mol Graph Model; 2016 Mar; 64():121-130. PubMed ID: 26826801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidic boronic acids are potent cell-permeable inhibitors of the malaria parasite egress serine protease SUB1.
    Lidumniece E; Withers-Martinez C; Hackett F; Collins CR; Perrin AJ; Koussis K; Bisson C; Blackman MJ; Jirgensons A
    Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33975947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtilisin-like Serine Protease 1 (SUB1) as an Emerging Antimalarial Drug Target: Current Achievements in Inhibitor Discovery.
    Lidumniece E; Withers-Martinez C; Hackett F; Blackman MJ; Jirgensons A
    J Med Chem; 2022 Oct; 65(19):12535-12545. PubMed ID: 36137276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The malaria parasite egress protease SUB1 is activated through precise, plasmepsin X-mediated cleavage of the SUB1 prodomain.
    Withers-Martinez C; George R; Maslen S; Jean L; Hackett F; Skehel M; Blackman MJ
    Biochim Biophys Acta Gen Subj; 2024 Sep; 1868(9):130665. PubMed ID: 38969256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the
    Mukherjee S; Nasamu AS; Rubiano KC; Goldberg DE
    mBio; 2023 Apr; 14(2):e0067323. PubMed ID: 37036362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel Plasmodium-specific prodomain fold regulates the malaria drug target SUB1 subtilase.
    Giganti D; Bouillon A; Tawk L; Robert F; Martinez M; Crublet E; Weber P; Girard-Blanc C; Petres S; Haouz A; Hernandez JF; Mercereau-Puijalon O; Alzari PM; Barale JC
    Nat Commun; 2014 Sep; 5():4833. PubMed ID: 25204226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prodomain-driven enzyme dimerization: a pH-dependent autoinhibition mechanism that controls
    Martinez M; Bouillon A; Brûlé S; Raynal B; Haouz A; Alzari PM; Barale J-C
    mBio; 2024 Mar; 15(3):e0019824. PubMed ID: 38386597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A malaria parasite subtilisin propeptide-like protein is a potent inhibitor of the egress protease SUB1.
    Tarr SJ; Withers-Martinez C; Flynn HR; Snijders AP; Masino L; Koussis K; Conway DJ; Blackman MJ
    Biochem J; 2020 Jan; 477(2):525-540. PubMed ID: 31942933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D structures of the Plasmodium vivax subtilisin-like drug target SUB1 reveal conformational changes to accommodate a substrate-derived α-ketoamide inhibitor.
    Martinez M; Batista FA; Maurel M; Bouillon A; Ortega Varga L; Wehenkel AM; Le Chevalier-Sontag L; Blondel A; Haouz A; Hernandez JF; Alzari PM; Barale JC
    Acta Crystallogr D Struct Biol; 2023 Aug; 79(Pt 8):721-734. PubMed ID: 37428845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A key role for Plasmodium subtilisin-like SUB1 protease in egress of malaria parasites from host hepatocytes.
    Tawk L; Lacroix C; Gueirard P; Kent R; Gorgette O; Thiberge S; Mercereau-Puijalon O; Ménard R; Barale JC
    J Biol Chem; 2013 Nov; 288(46):33336-46. PubMed ID: 24089525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The malaria parasite egress protease SUB1 is a calcium-dependent redox switch subtilisin.
    Withers-Martinez C; Strath M; Hackett F; Haire LF; Howell SA; Walker PA; Christodoulou E; Dodson GG; Blackman MJ
    Nat Commun; 2014 May; 5():3726. PubMed ID: 24785947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multifunctional serine protease primes the malaria parasite for red blood cell invasion.
    Koussis K; Withers-Martinez C; Yeoh S; Child M; Hackett F; Knuepfer E; Juliano L; Woehlbier U; Bujard H; Blackman MJ
    EMBO J; 2009 Mar; 28(6):725-35. PubMed ID: 19214190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of recombinant Plasmodium falciparum subtilisin-like protease-1 in insect cells. Characterization, comparison with the parasite protease, and homology modeling.
    Withers-Martinez C; Saldanha JW; Ely B; Hackett F; O'Connor T; Blackman MJ
    J Biol Chem; 2002 Aug; 277(33):29698-709. PubMed ID: 12052828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights from structure-activity relationships and the binding mode of peptidic α-ketoamide inhibitors of the malaria drug target subtilisin-like SUB1.
    Legru A; Batista FA; Puszko AK; Bouillon A; Maurel M; Martinez M; Ejjoummany A; Ortega Varga L; Adler P; Méchaly A; Hadjadj M; Sosnowski P; Hopfgartner G; Alzari PM; Blondel A; Haouz A; Barale JC; Hernandez JF
    Eur J Med Chem; 2024 Apr; 269():116308. PubMed ID: 38503166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing of Plasmodium falciparum Merozoite Surface Protein MSP1 Activates a Spectrin-Binding Function Enabling Parasite Egress from RBCs.
    Das S; Hertrich N; Perrin AJ; Withers-Martinez C; Collins CR; Jones ML; Watermeyer JM; Fobes ET; Martin SR; Saibil HR; Wright GJ; Treeck M; Epp C; Blackman MJ
    Cell Host Microbe; 2015 Oct; 18(4):433-44. PubMed ID: 26468747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocatalytic activation of a malarial egress protease is druggable and requires a protein cofactor.
    Tan MSY; Koussis K; Withers-Martinez C; Howell SA; Thomas JA; Hackett F; Knuepfer E; Shen M; Hall MD; Snijders AP; Blackman MJ
    EMBO J; 2021 Jun; 40(11):e107226. PubMed ID: 33932049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular determinants of binding to the Plasmodium subtilisin-like protease 1.
    Fulle S; Withers-Martinez C; Blackman MJ; Morris GM; Finn PW
    J Chem Inf Model; 2013 Mar; 53(3):573-83. PubMed ID: 23414065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and characterization of catalytic domain of Plasmodium falciparum subtilisin-like protease 3.
    Alam A; Bhatnagar RK; Chauhan VS
    Mol Biochem Parasitol; 2012 May; 183(1):84-9. PubMed ID: 22285468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.